BrachyThermix is a start up oncology device company formed in 2018, based in the Philadelphia area. In partnership with Thomas Jefferson University, BrachyThermix is developing a novel technology to significantly enhance the therapeutic benefit of radiation treatment following surgical resection of difficult to treat brain tumors such as glioblastoma.
Mid-Atlantic Bio Angels (MABA) announced on April 17th 2019 that BrachyThermix was named “Best in Show” by the audience at MABA’s 1st Pitch Life Science event held on April 8, 2019 at Baker Hostetler, Cira Center in Philadelphia. “1st Pitch provides a unique forum to present our company to investors without the pressure of having funding […]
BrachyThermix has made a series of poster and oral presentations at scientific meetings in 2018. On October 29th a poster was presented at Partners in Science Symposium at the 2018 Life Sciences Future Meeting in Philadelphia, PA. The poster described the clinical rationale and preliminary scientific investigations that demonstrate proof of concept for our project. […]
BrachyThermix received the Stephen M. Goodman Most Valued Company award at the Keiretsu Forum Mid-Atlantic Angel Capital Expo held in Philadelphia on October 17th 2018. The award is based on a vote of the attendees present at the meeting. BrachyThermix President and CEO, Dick Woodward, is seen receiving the award from Colleen Bevenour, Area Vice […]
BrachyThermix CEO Richard Woodward and Paul Stauffer (seated), founding scientist and inventor, will be among the 12 companies pitching to investors at Keiretsu Forum Mid-Atlantic’s Angel Capital Expo on October 17. In partnership with Thomas Jefferson University, they are developing a medical device that will provide simultaneous and uniform heat and radiation treatment of a […]